Methicillin 내성 포도구균과 Vancomycin 내성 장구균에 대한 Daptomycin의 시험관내 항균력

참고문헌 (24)

1. "The current status of surveillance of resistance to antimicrobial agents:report on a meeting", 49, pp.17~23 (2002)
2. "Bacterial resistance:origins,epidemiology,and impact", 36, pp.11~23 (2003)
3. "Gram-positive resistance:challenge for the development of new antibiotics", 39, pp.1~6 (1997)
4. "Increasing Prevalence of Vancomycin-Resistant Enterococci, and Cefoxitin-, Imipenem- and Fluoroquinolone-Resistant Gram-Negative Bacilli", 45, pp.598~608 (2004)
5. "Cubicin (daptomycin) package insert" (2003), Cubist Pharmaceuticals
6. "Daptomycin: a novel agent for gram-positive infections", 8, pp.1223~1238 (1999)
7. "Development of daptomycin for gram-positive infections", 46, pp.523~526 (2000)
8. "Lipoteichoic acid as a target for antimicrobial action", 2, pp.85~89 (1996)
9. "Lipoteichoic acid as a new target for activity of antibiotics mode of action of daptomycin", pp.1220~6 (1990)
10. "Daptomycin disrupts membrane potential in growing Staphylococcus aureus", 35, pp.2282~7 (1991)
11. "Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus", 47, pp.2538~2544 (2003)
12. "Resistance studies with daptomycin", 45, pp.1799~1802 (2001)
13. "Daptomycin susceptibility tests:interpretive criteria,quality control,and effect of calcium on in vitro tests", 38, pp.51~58 (2000)
14. "Activity of daptomycin against gram-positive pathogens:a comparison with other agents and the determination of a tentative breakpoint", 48, pp.563~567 (2001)
15. "The effect of cultural conditions on the activity of LY146032 against staphylococci and streptococci", 20, pp.213~21 (1987)
16. "Performance standards for antimicrobial susceptibility testing" (2005), Clinical and Laboratory Standards Institute
17. "In vitro activity of daptomycin (LY146032) and paldimyin (U-70, 138F) against anaerobic gram-positive bacteria", pp.788~70 90 (1988)
18. "In-vitro activity of LY146032 daptomycin and other agents against JK diphtheroids", 21, pp.807~8 (1988)
19. "Daptomycin activity and spectrum: a worldwide sample of 6,737 clinical gram-positive organisms", 53, pp.669~674 (2004)
20. "Daptomycin in vitro susceptibility in European gram-positive clinical isolates", 24, pp.59~66 (2004)
21. "Novel agents for the treatment of resistant gram-positive infections", 12, pp.117~137 (2003)
22. "Daptomycin versus conventional therapy in the treatment of endocarditis and bacteremia Paper presented at 31st Interscience Conference on Antimicrobial Agents and Chemotherapy"
23. "Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy", 49, pp.1664~1665 (2005)
24. "In vitro selection of bacteria resistant to LY146032,a new cyclic lipopeptide", 32, pp.24~6 (1988)

관련 논문AI추천